Literature DB >> 36147408

Comparative evaluation of nebulized ketamine and its combination with dexmedetomidine as premedication for paediatric patients undergoing surgeries under general anaesthesia.

Shital A Dharamkhele1, Shalendra Singh2, M S Honwad3, Venkata Krishna Gollapalli4, Nipun Gupta5.   

Abstract

Background: Various drugs have been endorsed but no standardised premedication protocol exists for paediatric patients. Nebulised form of drug not only results in better patient acceptability but also has improved clinical effectiveness. The present study delineates and evaluates the efficacy and safety of nebulised ketamine and combination of nebulised dexmedetomidine and ketamine for premedication in paediatric patients.
Methods: Prospective randomised controlled study was planned in patients, 3-10 years of age, undergoing surgeries. Patients received either nebulised ketamine (2 mg/kg) (group X, n = 23) or dexmedetomidine 1 μg/kg plus ketamine (1 mg/kg) (group Y; n = 24), 30 min before shifting inside the operation theatre. The sedation level, haemodynamic response and ill-effects were recorded for 30 min.
Results: The baseline haemodynamic (HR, MAP, RR and SpO2) parameters were normal and comparable in both the groups. There was no significant variation noticed in terms of HR, MAP, RR and SpO2% in either of the groups at 15 min (p < 0.15, p < 0.20, p < 0.85, p < 0.46) and 30 min (p < 0.21, p < 0.97, p < 0.75, p < 0.61) respectively, after receiving premedication. The level of sedation in group Y (score of 4 or less) was found to be better than that achieved by group X patients (p < 0.001). Face mask acceptance was satisfactory in group Y (score of 2 or less) as compared to group X patients (p < 0.001). The parental separation was comparable in both groups (p = 0.46).
Conclusion: Nebulisation is a satisfactory method of premedication for children. A combination of nebulised ketamine with a dose of 1 mg/kg and dexmedetomidine with a dose of 1 μg/kg is capable of producing a satisfactory level of sedation in a more effective manner than sedation induced by nebulised ketamine alone (2 mg/kg).
© 2021 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Entities:  

Keywords:  Dexmedetomidine; Ketamine; Nebulisation; Premedication

Year:  2021        PMID: 36147408      PMCID: PMC9485766          DOI: 10.1016/j.mjafi.2020.11.015

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  19 in total

Review 1.  Drug delivery to the central nervous system: a review.

Authors:  Ambikanandan Misra; S Ganesh; Aliasgar Shahiwala; Shrenik P Shah
Journal:  J Pharm Pharm Sci       Date:  2003 May-Aug       Impact factor: 2.327

Review 2.  Intranasal medication delivery for children: a brief review and update.

Authors:  Timothy R Wolfe; Darren A Braude
Journal:  Pediatrics       Date:  2010-08-09       Impact factor: 7.124

3.  A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine.

Authors:  Vivian M Yuen; Michael G Irwin; Theresa W Hui; Man K Yuen; Libby H Y Lee
Journal:  Anesth Analg       Date:  2007-08       Impact factor: 5.108

4.  Nebulized ketamine for successful management of difficult airway.

Authors:  Abdelghafour Elkoundi; Mustapha Bensghir; Salim Jaafar Lalaoui
Journal:  J Clin Anesth       Date:  2017-07-03       Impact factor: 9.452

5.  A comparative evaluation of nebulized dexmedetomidine, nebulized ketamine, and their combination as premedication for outpatient pediatric dental surgery.

Authors:  Ola M Zanaty; Shahira Ahmed El Metainy
Journal:  Anesth Analg       Date:  2015-07       Impact factor: 5.108

6.  Bioavailability of dexmedetomidine after intranasal administration.

Authors:  Timo Iirola; Sanna Vilo; Tuula Manner; Riku Aantaa; Maria Lahtinen; Mika Scheinin; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2011-02-12       Impact factor: 2.953

7.  Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.

Authors:  J W Miller; R Balyan; M Dong; M Mahmoud; J E Lam; J N Pratap; J R Paquin; B L Li; J P Spaeth; A Vinks; A W Loepke
Journal:  Br J Anaesth       Date:  2018-03-13       Impact factor: 9.166

8.  Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors.

Authors:  Zeev N Kain; Alison A Caldwell-Andrews; Inna Maranets; Brenda McClain; Dorothy Gaal; Linda C Mayes; Rui Feng; Heping Zhang
Journal:  Anesth Analg       Date:  2004-12       Impact factor: 5.108

9.  Comparison of nebulised dexmedetomidine, ketamine, or midazolam for premedication in preschool children undergoing bone marrow biopsy.

Authors:  H S Abdel-Ghaffar; S M Kamal; F A El Sherif; S A Mohamed
Journal:  Br J Anaesth       Date:  2018-06-22       Impact factor: 9.166

10.  Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial.

Authors:  Saad A Sheta; Maha A Al-Sarheed; Ashraf A Abdelhalim
Journal:  Paediatr Anaesth       Date:  2013-11-15       Impact factor: 2.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.